BD Extends Leadership in Advanced Tissue Regeneration Through Continued Clinical Innovation
Go back to BD Extends Leadership in Advanced Tissue Regeneration Through Continued Clinical Innovation| Becton Dickinson (NYSE: BDX) | Delayed: 189.61 -0.6 (0.32%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $190.21 | 52 Week High | $181.76 | |||
| Open | $189.29 | 52 Week Low | $129.50 | |||
| Day High | $190.41 | P/E | 40.43 | |||
| Day Low | $187.73 | EPS | $4.69 | |||
| Volume | 584,741 | |||||
